First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent

Winnie Bergstedt, Pernille N. Tingskov, Birgit Thierry-Carstensen et al. · 2010

Read First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent by Winnie Bergstedt, Pernille N. Tingskov, Birgit Thierry-Carstensen et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011277.txt.

Description

Bergstedt, Tingskov, Thierry-Carstensen and colleagues ran a first human trial in PLOS ONE in 2010. Tuberculosis skin tests are old and often unclear, since prior BCG vaccination confuses results. The team tested a new reagent combining two proteins specific to the TB germ in volunteers for the first time.

A specific skin test could catch TB sooner and sort true infection from vaccine effects. That distinction matters in countries where BCG is routine. The trial checks safety and response as first steps toward clinic use. Better detection helps curb spread by finding infectious people earlier.

Catalog record

CREATORWinnie Bergstedt, Pernille N. Tingskov, Birgit Thierry-Carstensen et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011277

Browse the full library · About the Tower of Babel